• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Comprehensive Overview of (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol (CAS No. 100696-04-6): Properties, Applications, and Industry Insights

The compound (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol (CAS No. 100696-04-6) is a chiral cyclohexane derivative with significant relevance in pharmaceutical and chemical research. Its stereospecific structure, featuring a propan-2-yl amino group and a hydroxyl group on a cyclohexane backbone, makes it a valuable intermediate in asymmetric synthesis and drug development. The (1S,2S) configuration ensures high enantiomeric purity, a critical factor for applications requiring precise molecular interactions.

In recent years, the demand for chiral compounds like (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol has surged due to their role in designing targeted therapeutics and catalysts. Researchers frequently search for "chiral building blocks" or "enantioselective synthesis," reflecting the growing interest in stereochemically defined molecules. This compound’s CAS No. 100696-04-6 is often referenced in patents and academic papers, highlighting its utility in medicinal chemistry and process optimization.

The physicochemical properties of (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol include moderate solubility in polar solvents, stability under ambient conditions, and a defined melting point range, making it suitable for laboratory and industrial-scale applications. Its amino-alcohol functionality allows for versatile derivatization, enabling the creation of ligands for metal-catalyzed reactions or pharmacophores in drug discovery. These attributes align with trending topics like "green chemistry" and "sustainable synthesis," as the compound can reduce waste in multi-step reactions.

From an industrial perspective, CAS No. 100696-04-6 is often discussed in contexts such as "scale-up challenges" and "cost-effective chiral synthesis." Companies optimizing API production (Active Pharmaceutical Ingredients) prioritize such intermediates for their reproducibility and scalability. Additionally, the compound’s role in asymmetric hydrogenation—a hot topic in catalysis—further underscores its importance.

Regulatory and safety profiles of (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol are well-documented, with no significant hazards under standard handling conditions. This aligns with the increasing focus on "safe chemical handling" and "regulatory compliance" in search queries. Its non-toxic nature and compatibility with GMP standards make it a preferred choice for pharmaceutical manufacturers.

In conclusion, (1S,2S)-2-(Propan-2-yl)aminocyclohexan-1-ol (CAS No. 100696-04-6) exemplifies the intersection of chiral chemistry and industrial applicability. Its versatility, coupled with rising demand for enantiopure compounds, positions it as a critical component in modern synthetic strategies. As research trends evolve toward precision medicine and catalytic efficiency, this compound will likely remain a focal point for innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)